Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gini Fleming
ETOP IBCSG Partners Foundation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
500 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bcca-Cancer Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Penticton Regional Hospital
Penticton, British Columbia, Canada
- Bcca-Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
- Bcca-Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Doctor H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
- Health Sciences North
Greater Sudbury, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston General Hospital
Kingston, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Ottawa Hospital and Cancer Center-General Campus
Ottawa, Ontario, Canada
- Thunder Bay Regional Health Science Centre
Thunder Bay, Ontario, Canada
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Csss Champlain-Charles Le Moyne
Greenfield Park, Quebec, Canada
- Chum-Hotel Dieu Du Montreal
Montreal, Quebec, Canada
- Hopital Du Sacre-Coeur de Montreal
Montreal, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- International Breast Cancer Study Group
Bern, Switzerland
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills - Peninsula Hospitals
Burlingame, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California, United States
- John Muir Medical Center-Concord Campus
Concord, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Valley Medical Oncology Consultants-Fremont
Fremont, California, United States
- Glendale Memorial Hospital and Health Center
Glendale, California, United States
- Marin General Hospital
Greenbrae, California, United States
- Scripps Cancer Center
La Jolla, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Sutter Cancer Research Consortium
Novato, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Dec 2003
- Primary completion
- 31 May 2014
- Completion
- 6 Nov 2024
- Last update posted
- 6 Feb 2026
- Registered enrollment
- 3,066
- Registry id
- NCT00066690
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.